SCHEMBL9937883

SCHEMBL9937883

Oc1cc2c3c(ccc2c2ccccc12)C=CC3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.41
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
IDO1 P14902 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
MYC P01106 1/20 0.35
MAX P61244 1/20 0.35
DYRK1A Q13627 1/20 0.35
THRB P10828 1/20 0.33
NQO2 P16083 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NSD2 O96028 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
MCL1 Q07820 1/20 0.32
EP300 Q09472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29602086 0.85 PDE2A (0.34) DYRK1AKDM4EKMT2A
SCHEMBL16226030 0.79 TRPM4 (0.41) TRPM4CA12CA1CA9IDO1
SCHEMBL30541938 0.75 HPRT1 (0.52) LMNATHRBMAPTMEN1KMT2A
SCHEMBL159626 0.75 HPRT1 (0.52) LMNATHRBMAPTMEN1KMT2A
SCHEMBL30446008 0.75 HPRT1 (0.52) LMNATHRBMAPTMEN1KMT2A
SCHEMBL12475251 0.75 HPRT1 (0.52) LMNATHRBMAPTMEN1KMT2A
SCHEMBL31497107 0.75 HPRT1 (0.52) LMNATHRBMAPTMEN1KMT2A
SCHEMBL16114571 0.75 KDM4E (0.31) THRBMAPTKDM4EMEN1POLB
Charcoal, Activated SCHEMBL3299280 0.74 HPRT1 (0.50) LMNAMAPTMEN1KMT2A
SCHEMBL15540285 0.73 HTT (0.47) LMNAHTTTHRBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed